Predictors of Adherence to Glatiramer Acetate Therapy in Individuals with Self-Reported Progressive Forms of Multiple Sclerosis*
The DOI matches its Crossref record.
Abstract
The purpose of this study was to evaluate psychological, biophysical, and sociodemographic variables as predictors of adherence to glatiramer acetate (Copaxone) therapy in individuals with self-reported progressive forms of multiple sclerosis (MS). The literature lends support for self-efficacy, self-esteem, hope, and disability to be predictors of adherence. Therefore the hypotheses for this study were (a) higher self-efficacy will be a significant predictor of adherence, (b) higher self-esteem will be a significant predictor of adherence, (c) higher hope will be a significant predictor of adherence, and (d) a lower level of disability will be a significant predictor of adherence. The MS Self-Efficacy Scale (MSSE), Rosenberg Self-Esteem Scale, Herth Hope Index, and Performance Scales; a sociodemographic questionnaire; and an information sheet regarding consent to participate in the study were mailed to 1,200 potential participants. A total of 594 individuals responded, and for the evaluation of predictors of adherence in individuals with self-reported progressive forms of MS, 199 met the criteria. Logistic regression analysis revealed four significant predictors of adherence: the MSSE Control subscale, MSSE Function subscale, perceived support of the physician, and perceived support of the spouse. The higher the score on the MSSE Control subscale, the more likely the individual will adhere to glatiramer acetate therapy. The higher the score on the MSSE Function subscale, the more likely the individual will adhere to glatiramer acetate therapy. The MSSE Control and Function subscales show promise of being useful to predict adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kato, P. M., Cole, S. W., Bradlyn, A. S., & Pollock, B. H. (2008) · Pediatrics · doi:10.1542/peds.2007-3134 · Cited by 802
Náfrádi, L., Nakamoto, K., & Schulz, P. J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186458 · Cited by 543
Devonshire, V., Lapierre, Y., Macdonell, R., Ramo‐Tello, C., Patti, F., Fontoura, P., Suchet, L., Hyde, R., Balla, I., Frohman, E. M., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03110.x · Cited by 340
Factors that influence adherence with disease-modifying therapy in MS
Treadaway, K., Cutter, G., Salter, A., Lynch, S., Simsarian, J., Corboy, J., Jeffery, D., Cohen, B., Mankowski, K., Guarnaccia, J., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0096-y · Cited by 258
Holmes, E. A. F., Hughes, D. A., & Morrison, V. L. (2014) · Value in Health · doi:10.1016/j.jval.2014.08.2671 · Cited by 199
Metadata
- Authors
- Fraser, C., Hadjimichael, O., & Vollmer, T.
- Venue
- Journal of Neuroscience Nursing
- Published
- 2003-06
- Volume
- 35
- Issue
- 3
- Pages
- 163-170
- ISSN
- 0888-0395 (ISSN-L)
- OpenAlex
- W2331315977
- Cited by
- 41
- References
- 0
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of Adherence to Glatiramer Acetate Therapy in Individuals with Self-Reported Progressive Forms of Multiple Sclerosis*. https://app.cochat.ai/papers/10.1097/01376517-200306000-00006
- The paper
- Fraser, C., Hadjimichael, O., & Vollmer, T. (2003). Predictors of Adherence to Glatiramer Acetate Therapy in Individuals with Self-Reported Progressive Forms of Multiple Sclerosis*. Journal of Neuroscience Nursing. https://doi.org/10.1097/01376517-200306000-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.